Pomalidomide in combination with dexamethasone approved for use in refractory multiple myeloma

被引：0
|
作者：
Brown, Emily
机构：
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2013年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：516 / 517
页数：2
相关论文
共 50 条
  • [21] ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma
    Mark, Tomer M.
    Boyer, Angelique
    Rossi, Adriana C.
    Shah, Manan
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Tegnestam, Linda
    Sacris, Erlinda A.
    Greenberg, June
    Speaker, Stephanie
    Jayabalan, David
    Ely, Scott A.
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    BLOOD, 2012, 120 (21)
  • [22] Clarithromycin, pomalidomide, and dexamethasone (ClaPD) in relapsed or refractory multiple myeloma.
    Rossi, Adriana C.
    Mark, Tomer Martin
    Rodriguez, Melissa
    Shah, Manan
    Quinn, Ryann
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Speaker, Stephanie
    Jayabalan, David
    Ely, Scott
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Selinexor, Pomalidomide, and Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Christine I.
    Bahlis, Nizar
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea C.
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    Leblanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie Scott
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2019, 134
  • [24] Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Early Relapsed/ Refractory Multiple Myeloma
    Kumar, Anupama
    Rosenberg, Aaron S.
    Padilla, Michelle
    Shah, Nina
    Sirianni, Lindsey
    Liu, Lin
    Cheng, Yuwei
    Pittman, Emily
    Tzachanis, Dimitrios
    Larson, Sarah
    Mulroney, Carolyn
    Ball, Edward D.
    Costello, Caitlin
    BLOOD, 2022, 140 : 4436 - 4437
  • [25] EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma
    Delgado, Julio
    Zienowicz, Malgorzata
    van Hennik, Paula Boudewina
    Moreau, Alexandre
    Gisselbrecht, Christian
    Enzmann, Harald
    Pignatti, Francesco
    ONCOLOGIST, 2021, 26 (11): : 983 - 987
  • [26] Thalidomide and dexamethasone combination for refractory multiple myeloma
    Dimopoulos, MA
    Zervas, K
    Kouvatseas, G
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Vervessou, E
    Samantas, E
    Papadimitriou, C
    Economou, O
    Gika, D
    Panayiotidis, P
    Christakis, I
    Anagnostopoulos, N
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 991 - 995
  • [27] A phase II study of elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.
    Yee, Andrew Jenho
    Laubach, Jacob
    Campagnaro, Erica Leigh
    Lipe, Brea
    Nadeem, Omar
    Cole, Craig
    O'Donnell, Elizabeth
    Schlossman, Robert L.
    Bianchi, Giada
    Branagan, Andrew Robert
    Shapiro, Samantha J.
    Harrington, Cynthia C.
    Burke, Jill N.
    Gammon, Marilyn T.
    Lively, Kathleen J.
    Thorburn, Cassandra Ann
    Mann, Mason L.
    Lohr, Jens Guenter
    Richardson, Paul G.
    Raje, Noopur S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma
    Chen, Christine
    Kotb, Rami
    Sebag, Michael
    LeBlanc, Richard
    Sutherland, Heather J.
    White, Darrell
    Venner, Christopher P.
    Kouroukis, Tom
    Bergstrom, Debra
    McCurdy, Arleigh
    Lalancette, Marc
    Bensinger, William
    Lentzsch, Suzanne
    Del Col, Aldo
    Kauffman, Michael
    Shacham, Sharon
    Jeha, Jacqueline
    Picklesimer, Carla
    Saint-Martin, Jean-Richard
    Choe-Juliak, Cassandra
    Bahlis, Nizar J.
    BLOOD, 2016, 128 (22)
  • [29] Elotuzumab in Combination with Pomalidomide and Corticosteroids for Relapsed or Refractory Multiple Myeloma
    Sidiqi, Hasib
    McGregor, Scott
    Baker, Ross
    Carnley, Ben
    Radeski, Dejan
    Barraclough, Allison
    Augustson, Bradley
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E83 - E84
  • [30] Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
    Shah, Jatin J.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Cohen, Adam D.
    Bensinger, William I.
    Gasparetto, Cristina
    Kaufman, Jonathan L.
    Lentzsch, Suzanne
    Vogl, Dan T.
    Gomes, Christina L.
    Pascucci, Natalia
    Smith, David D.
    Orlowski, Robert Z.
    Durie, Brian G. M.
    BLOOD, 2015, 126 (20) : 2284 - 2290
12345